பாலம் சோதனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாலம் சோதனைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாலம் சோதனைகள் Today - Breaking & Trending Today

DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines


DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines
Vaccines which have been approved by select regulatory bodies will not need to conduct bridging trials, the country s apex drug regulator said on Tuesday.
Vials labelled Moderna, Johnson & Johnson, Pfizer-BioNTech COVID-19 vaccine are seen in this illustration. Photo: ReutersS/Dado Ruvic
Health6 hours ago
New Delhi: In a move that is expected to smooth Pfizer and Moderna’s entry into the market, India’s top drug regulator on Tuesday exempted foreign-made COVD-19 vaccines from post-approval bridging trials in the country, if they are approved by certain health bodies.
Indian Express, companies such as Pfizer and Cipla have asked for these exemptions during negotiations to supply vaccines to the country. However, there does not seem to be any update on Pfizer’s demand to grant indemnity – protecting it from any legal action if the vaccine leads to serious side effects, although an ....

United Kingdom , Himachal Pradesh , New Delhi , Central Drugs Standard Control Organisation , Drugs Administration , European Medicines Agency , Central Drugs Laboratory , Devices Agency , National Control Laboratory , Healthcare Products Regulatory Agency , Serum Institute Of India , Indian Express , India Today , Drugs Controller General , Medical Devices Agency , National Expert Group , Vaccine Administration , Emergency Use , Serum Institute , Bharat Biotech , Bridging Trials , Bridging Trials For Covid Vaccines , Covid 19 , Covid 19 Vaccines , Covid 19 Vaccines Bridging Trials , Covid Vaccines ,

91.6% Efficacy, Rare Adverse Effects: All You Need to Know About Russia's Sputnik V Vaccine


91.6% Efficacy, Rare Adverse Effects: All You Need to Know About Russia s Sputnik V Vaccine
News18
1 hour ago
News18
Russia’s COVID-19 vaccine Sputnik V on Monday received approval of Centre’s expert panel for emergency use in India with certain conditions. The Drugs Controller General of India (DCGI) will take a final call on the recommendation of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), which took up the application of Dr Reddy’s Laboratories seeking emergency use authorisation for Sputnik V.
© Provided by News18
91.6% Efficacy, Rare Adverse Effects: All You Need to Know About Russia s Sputnik V Vaccine ....

Sri Lanka , South Korea , Saint Vincent And The Grenadines , Republic Of , Antigua And Barbuda , Republic Of The Congo , Republic Of Guinea , Saint Vincent , Oxford Astrazeneca Covishield , Arvinder Singh Soin , Denis Logunov , Stelis Biopharma , Institute Of Liver Transplantation , Russia Direct Investment Fund , Gamaleya National Research Centre For Epidemiology , Central Drugs Standard Control Organization , Serum Institute Of India , Expert Committee , Rare Adverse Effects , All You Need , Know About Russia , Sputnikv Vaccine , Drugs Controller General , Subject Expert Committee , Bharat Biotech , Serum Institute ,

Russia's Sputnik V Vaccine Gets Emergency Use Authorisation in India; All You Need to Know


Russia s Sputnik V Vaccine Gets Emergency Use Authorisation in India; All You Need to Know
News18
1 hour ago
News18
© Provided by News18
Russia s Sputnik V Vaccine Gets Emergency Use Authorisation in India; All You Need to Know
Russian COVID-19 vaccine Sputnik V was on Monday given approval for emergency use authorisation in India by the Subject Expert Committee (SEC), constituted by the central government. The SEC nod came on drugmaker Dr Reddy’s application seeking authorisation for the vaccine in India.
Dr Reddy’s has partnered with the Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India. India has been pledged 125 million doses of the vaccine by Russia. India, the world’s largest vaccine maker, has become one of the biggest producers of the Sputnik V shot outside Russia. Other countries producing it include Brazil, China and South Korea. RDIF has also partnered with Indian pharma firms such as Pan ....

South Korea , Arvinder Singh Soin , Denis Logunov , Stelis Biopharma , Institute Of Liver Transplantation , Russia Direct Investment Fund , Gamaleya National Research Centre For Epidemiology , Expert Committee , All You Need , Subject Expert Committee , Panacea Biotec , Gland Pharma , Serious Adverse Events , Sputnikv Vaccine Works , Gamaleya National Research Centre , Bridging Trials , Andhra Pradesh , Liver Transplantation , Regenerative Medicine , Medanta The Medicity , தெற்கு கொரியா , அரவிந்தர் சிங் மண் , நிறுவனம் ஆஃப் கல்லீரல் மாற்று அறுவை சிகிச்சை , ரஷ்யா நேரடி முதலீடு நிதி , நிபுணர் குழு , அனைத்தும் நீங்கள் தேவை ,